Boston Scientific completes acquisition of Axonics, Inc. to expand into sacral neuromodulation
11/15/24, 2:00 PM
Location
Industry
medical
biotechnology
health care
manufacturing
Boston Scientific Corporation has successfully closed its acquisition of Axonics, Inc., a medical technology company specializing in devices to treat urinary and bowel dysfunction. This acquisition allows Boston Scientific to expand into sacral neuromodulation, a high-growth adjacency for their Urology business, and to provide a comprehensive product portfolio to patients seeking tailored treatment options for incontinence.
Company Info
Location
Marlborough, Massachusetts, United States
Company info
Boston Scientific transforms lives through innovative medical technologies that improve the health of patients around the world. As a global medical technology leader for more than 40 years, we advance science for life by providing a broad range of high-performance solutions that address unmet patient needs and reduce the cost of health care. Our portfolio of devices and therapies helps physicians diagnose and treat complex cardiovascular, respiratory, digestive, oncological, neurological and urological diseases and conditions.